Stanley Laman Group, Ltd. Astrazeneca PLC Transaction History
Stanley Laman Group, Ltd.
- $648 Million
- Q3 2024
A detailed history of Stanley Laman Group, Ltd. transactions in Astrazeneca PLC stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 64,491 shares of AZN stock, worth $4.85 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
64,491
Previous 62,329
3.47%
Holding current value
$4.85 Million
Previous $4.86 Million
3.37%
% of portfolio
0.78%
Previous 0.76%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,343Shares Held
492MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$4.88 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.2 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.05 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.76 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.32 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...